A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Recruiting

Phase 3

BMS-986278A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Sponsor:

Bristol-Myers Squibb

Code:

NCT06025578

Conditions

Progressive Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-12. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2025-12-05.